George I. Papakostas, MD

Clinical Trials Network and Institute, Department of Psychiatry, Massachusetts General Hospital; and Department of Psychiatry, Harvard Medical School, Boston, Massachusetts

JCP
Original Research

December 23, 2015

Richard C. Shelton, Michael J. Pencina, Lori W. Barrentine, et al
JCP
Letter to the Editor

August 26, 2015

George I. Papakostas, Richard C. Shelton, Michael E. Henry, et al
JCP
Educational Activity

August 26, 2015

George I. Papakostas
JCP
Educational Activity

June 24, 2015

George I. Papakostas
JCP
Academic Highlights

April 22, 2015

Patients with MDD may experience cognitive dysfunctions that make recovery difficult or incomplete. Read this new Academic Highlights to learn to understand and identify problems with cognition in depressed...
George I. Papakostas, Larry Culpepper
JCP
Original Research

February 25, 2015

John A. Bilello, Linda M. Thurmond, Katie M. Smith, et al
JCP
Review Article

February 3, 2015

George I. Papakostas, Søren D. Østergaard, Nadia Iovieno
JCP
ASCP Corner

December 24, 2014

George I. Papakostas, Dawn F. Ionescu
JCP
Academic Highlights

December 24, 2014

Understand what is Vortioxetine (Brintellix), an antidepressant for major depressive disorder and treatment-resistant depression.
Alan F. Schatzberg, Pierre Blier, Larry Culpepper, et al
JCP
Letter to the Editor

November 24, 2014

David Mischoulon, Lawrence H. Price, Linda L. Carpenter, et al
JCP
Original Research

April 15, 2014

George I. Papakostas, Richard C. Shelton, John M. Zajecka, et al
JCP
Original Research

December 24, 2013

David Mischoulon, Lawrence H. Price, Linda L. Carpenter, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe